Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04943835 · ClinicalTrials.gov registry record

Validity of a Test of Functional Cognition in Persons With Acquired Brain Injury

A clinical trial, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
73
Enrollment target

NCT04943835: Completed study, sponsored by Weill Medical College of Cornell University.

NCT04943835 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04943835 has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
73 participants
Enrollment target

Study Summary

The purpose of this study is to test the validity of the Weekly Calendar Planning Activity (WCPA), a test of functional cognition in persons with acquired brain injury. We will formally examine the utility, baseline profile and validity of the WCPA with adults ages 21 and above with acquired brain injury for both the WCPA 17 and WCPA 10 versions.

Primary Outcome

The Weekly Calendar Planning Activity (WCPA) is a performance-based Cognitive Instrumental activities of daily living (C-IADL) task that requires working memory, planning, shifting, inhibition, and self-monitoring. The WCPA requires the examinee to input a series of 10 appointments, into a mock weekly calendar/schedule while following multiple rules, managing appointment conflicts, ignoring distracting questions by the examiner and keeping track of time. WCPA percent accuracy is the number of ap

Interventions

  • OTHER Observational - No intervention

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2017-01-12
Est. Completion 2020-02-05

What the finished NCT04943835 record still lists

NCT04943835 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Observational - No intervention is the first listed.

NCT04943835 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04943835 about?

NCT04943835 is a clinical study titled "Validity of a Test of Functional Cognition in Persons With Acquired Brain Injury". The purpose of this study is to test the validity of the Weekly Calendar Planning Activity (WCPA), a test of functional cognition in persons with acquired brain injury. We will formally examine the utility, baseline profile and validity of the WCPA with adults ages 21 and above with acquired brain i...

What is the current status of trial NCT04943835?

This trial is currently completed. The enrollment target is 73 participants. The study started on 2017-01-12. Estimated completion is 2020-02-05.

What interventions are being tested in trial NCT04943835?

The interventions under investigation include: Observational - No intervention (OTHER).

Who is sponsoring clinical trial NCT04943835?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03661307 · 73 participants · Phase 1

    Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

  • NCT05386108 · 73 participants · Phase 1

    Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • NCT05961592 · 73 participants · Phase 1

    R-2487 in Patients With Rheumatoid Arthritis

  • NCT06150664 · 73 participants · Phase 1

    A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04943835, the US trial registry maintained by the National Library of Medicine. NCT04943835 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.